COP vs MXCT · P/E 19, rev $58.94B vs rev $38.6M
ConocoPhillips (COP) versus MaxCyte Inc (MXCT) — a side-by-side from cached financials, not a winner call.
ConocoPhillips (COP) is a oil & gas e&p company listed on NYSE. It is led by Ryan Lance.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
Latest reported COP revenue for 2025-12-31 was $58.94B. Net income was $7.99B. Revenue was up 7.7% from 2024-12-31 to 2025-12-31. COP currently screens at market cap $135.49B and trailing P/E 18.8.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
COP currently screens at market cap $135.49B and trailing P/E 18.8. MXCT currently screens at market cap $124.3M.
Not investment advice. Open the COP and MXCT stock pages for the full models.
Not investment advice.